BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways.
BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways. Cell Oncol (Dordr). 2020 Dec; 43(6):1049-1066.